Treatment of multiple myeloma KMS11 cells with dexamethasone resulted in the induction of Bim as an essential element of dex-induced cell lethality, while at the same time causing a significant reduction in the IC50 of subsequent obatoclax treatment. Here, BCL2L11 is linked to plasma cell myeloma.